Tellus Therapeutics
About:
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
Website: http://www.tellustherapeutics.com/
Top Investors: Xontogeny, North Carolina Biotechnology Center, MassChallenge, One North Carolina Small Business Program
Description:
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. It was founded in 2018 and is based in Hillsborough, North Carolina.
Total Funding Amount:
$53.5M
Headquarters Location:
Hillsborough, North Carolina, United States
Founded Date:
2018-01-01
Founders:
Jason Kralic
Number of Employees:
1-10
Last Funding Date:
2023-02-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai